Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir 5 vs 10 Days for Post-Exposure Influenza Prophylaxis
NCT07496736Phase 3Active, not recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Dec 2025
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oseltamivir in influenza, sponsored by University Medical Centre Ljubljana. Started Dec 2025; status: active, not recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07496736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496736.